Gelesis, Inc. IPO Research Information

Gelesis, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Gelesis, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Gelesis, Inc.	GLSS - NASDAQ	$12.00-$14.00	$0.00	$0.00	4 million
Underwriter(s): Piper Jaffray, Stifel, Guggenheim Securities
Co-Manager(s):
Industry:
Filing(s): Filed 2015-04-01 Terms Added 2015-04-23

About Gelesis, Inc. (adapted from Gelesis, Inc. prospectus):
They are a biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, or management of blood sugar levels, in overweight and obese patients, including those with prediabetes and type 2 diabetes.

This description is adapted from Gelesis-GLSS prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Gelesis-GLSS "GLSS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.